1887

Abstract

Growth of gonococci in the presence of CMP--acetylneuraminic acid (CMP-NANA) has previously been shown to induce resistance to the bactericidal effect of normal human serum and is accompanied by sialylation of the gonococcal lipopolysaccharide (LPS). We have used monoclonal antibodies (mAbs) to compare the effect of LPS sialylation on recognition of gonococci and complement-mediated killing by antibodies directed either against LPS or against defined epitopes on outer-membrane protein PI. Despite differences in binding to sialylated LPS on Western blots, all three mAbs directed against LPS showed considerably reduced binding to gonococci grown in the presence of CMP-NANA and a concomitant reduction in ability to promote complement-mediated killing. In contrast, mAbs directed against previously defined epitopes on a surface exposed loop of PI showed little difference in binding between sialylated and non-sialylated gonococci and promoted killing of the sialylated gonococci. Similarly a mAb directed against an epitope on a loop of the outer-membrane Rmp protein, which had previously been shown to block killing by antibodies directed against other surface antigens, also exerted a blocking effect with sialylated gonococci. Thus in the present study the continued biological effect of mAbs was correlated with the ability of the antibody to recognize surface-exposed epitopes on sialylated gonococci. Despite the presence of the sialylation which is likely to occur , it should be possible to induce complement-mediated killing by focusing the immune response to those surface-exposed epitopes which are least susceptible to the potential inhibitory effect of LPS sialylation.

Loading

Article metrics loading...

/content/journal/micro/10.1099/13500872-141-4-913
1995-04-01
2024-11-13
Loading full text...

Full text loading...

/deliver/fulltext/micro/141/4/mic-141-4-913.html?itemId=/content/journal/micro/10.1099/13500872-141-4-913&mimeType=html&fmt=ahah

References

  1. Apicella M. A., Westerink M. A. J., Morse S. A., Schneider H., Rice P. A., Griffiss J. M. 1986; Bactericidal antibody response of normal human serum to the lipooligosaccharide of Neisseria gonorrhoeae . J Infect Dis 153:520–526.
    [Google Scholar]
  2. Brunham R. C., Plummer F., Slaney L., Rand F., DeWitt W. 1985; Correlation of auxotype and protein I type with expression of disease due to Neisseria gonorrhoeae . J Infect Dis 152:339–343.
    [Google Scholar]
  3. Buchanan T. M., Esenbach D. A., Knapp J. S., Holmes K. K. 1980; Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigen type . Am J Ohstet Gynecol 138:978–980
    [Google Scholar]
  4. Butt N. J., Virji M., Vayreda F., Lambden P. R., Heckels J. E. 1990; Gonococcal outer membrane protein PIB: comparative sequence analysis and localization of epitopes which are recognized by type-specific and cross-reacting monoclonal antibodies. J Gen Microbiol 136:2165–2172.
    [Google Scholar]
  5. Carbonetti N. H., Sparling P. F. 1987; Molecular cloning and characterization of the structural gene for protein I, the major outer membrane protein of Neisseria gonorrhoeae . Proc Natl Acad Sci USA 84:9084–9088.
    [Google Scholar]
  6. Christodoulides M., McGuinness B. T., Heckels J. E. 1993; Immunization with synthetic peptides containing epitopes of the class 1 outer membrane protein of Neisseria meningitidis: production of bactericidal antibodies on immunization with a cyclic peptide. J Gen Microbiol 139:1729–1738.
    [Google Scholar]
  7. Donegan S. P., Jani D. B., Flaherty E. E., Heeren T. C., Rice P. A. 1994; The male to female transmission of Neisseria gonorrhoeae is influenced by level of antibody to gonococcal reduction modifiable protein (Rmp) or PIII. In Neisseria 1992:645–650 Edited by C. J. Conde-Glex. Mexico: Publications Office of the Nacional de Salud Publica.;
    [Google Scholar]
  8. Elkins C., Carbonetti N. H., Varela V. A., Stirewalt D., Klapper D. G., Sparling P. F. 1992; Antibodies to N-terminal peptides of gonococcal porin are bactericidal when gonococcal lipopoly- saccharide is not sialylated. Mol Microbiol 6:2617–2628.
    [Google Scholar]
  9. Fletcher J. N., Zak K., Virji M., Heckels J. E. 1986; Monoclonal antibodies to gonococcal outer membrane protein I: location of a conserved epitope on protein IB. J Gen Microbiol 132:1611–1620
    [Google Scholar]
  10. Gotschlich E. C., Seiff M., Blake M. S. 1987a; The DNA sequence of the structural gene of gonococcal protein III and the flanking region containing a repetitive sequence homology of protein III with enterobacterial OmpA proteins. J Exp Med 165:471–482
    [Google Scholar]
  11. Gotschlich E. C., Seiff M. E., Blake M. S., Koomey M. 1987b; Porin protein of Neisseria gonorrhoeae: cloning and gene structure. Proc Natl Acad Sci USA 84:8135–8139
    [Google Scholar]
  12. Heckels J. E. 1993; Immune avoidance by pathogenic Neisseria . In Progress in Immunology pp VIII:667–674 Edited by J Gergely, M Benczur, A Erdei, A Falus, M Fust, G Medgyesi, G Petranyi, E Rajnavolgyi. Budapest : Springer Hungarica.:
    [Google Scholar]
  13. Heckels J. E., Virji M., Tinsley C. R. 1990; Vaccination against gonorrhoea: the potential protective effect of immunization with a synthetic peptide containing a conserved epitope of gonococcal outer membrane protein IB. Vaccine 8:225–230
    [Google Scholar]
  14. Hitchcock P. J., Brown T. M. 1983; Morphological heterogeneity among salmonella lipopolysaccharide chemotypes in silver stained polyacrylamide gels. J Bacteriol 154:269–277
    [Google Scholar]
  15. Ison C. A., Hadfield S. G., Bellinger C. M., Dawson S. G., Glynn A. A. 1986; The specificity of serum and local antibodies in female gonorrhoea. Clin Exp Immunol 65:198–205
    [Google Scholar]
  16. Judd R. C. 1982; Surface peptide mapping of protein I and protein III of four strains of Neisseria gonorrhoeae . Infect Immun 37:632–641
    [Google Scholar]
  17. Knapp J. S., Tam M. R., Nowinski R. C., Holmes K. K., Sandstrom E. G. 1984; Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis 50:44–48
    [Google Scholar]
  18. van der Ley P., Heckels J. E., Virji M., Hoogerhout P., Poolman J. T. 1991; Topology of outer membrane porins in pathogenic Neisseria species . Infect Immun 59:2963–2971
    [Google Scholar]
  19. Mandrell R. E., Lesse A. J., Sugai J. V., Shero M., Griffiss J. M., Cole J. A., Parsons N. J., Smith H., Morse S. A., Apicella M. A. 1990; In vitro and in vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J Exp Med 171:1649–1664
    [Google Scholar]
  20. Martin P. M. V., Patel P. V., Parsons N. J., Smith H. 1981; Induction of phenotypically determined resistance of Neisseria gonorrhoeae to human serum by factors in human serum. J Gen Microbiol 127:213–217
    [Google Scholar]
  21. Martin P. M. V., Patel P. V., Parsons N. J., Smith H. 1982; Induction in gonococci of phenotypic resistance to killing by human serum by human genital secretions. Brit J Ven Dis 58:363–365
    [Google Scholar]
  22. McGuinness B. T., Lambden P. R., Heckels J. E. 1993; Class 1 outer membrane protein of Neisseria meningitidis: epitope analysis of the antigenic diversity between strains, implications for subtype definition and molecular epidemiology. Mol Microbiol 7:505–514
    [Google Scholar]
  23. Mee B. J., Thomas H., Cooke S. J., Lambden P. R., Heckels J. E. 1993; Structural comparison and epitope analysis of outer membrane protein PIA from strains of Neisseria gonorrhoeae with differing serovar specificities. J Gen Microbiol 139:2613–2620
    [Google Scholar]
  24. Nairn C. A., Cole J. A., Patel P. V., Parsons N. J., Fox J. E. , Smith H. 1988; Cytidine 5' monophospho-N-acetylneuraminic acid or a related compound is the low M r factor from human red blood cells which induces gonococcal resistance to killing by human serum . J Gen Microbiol 134:3295–3306
    [Google Scholar]
  25. Parsons N. J., Ashton P. R., Constantinidou C., Cole J. A. H, Smith H. 1993; Identification by mass spectrometry of CMP- NANA in diffusible material released from high M(r) blood-cell fractions that confers serum resistance on gonococci. Microb Pathog 14:329–335
    [Google Scholar]
  26. Patel P. V., Martin P. M. V., Goldner M., Parsons N. J., Smith H. 1984; Red blood cells, a source of factors which induce Neisseria gonorrhoeae to resistance to complement-mediated killing by human serum. J Gen Microbiol 130:2767–2770
    [Google Scholar]
  27. Patel P. V., Parsons N. J., Andrade J. R. C., Nairn C. A., Tan E. L., Goldner M., Cole J. A., Smith H. 1988; White blood cells including polymorphonuclear phagocytes contain a factor which induces gonococcal resistance to complement mediated serum killing. FEMS Microbiol Lett 50:173–176
    [Google Scholar]
  28. Plummer F. A., Simonsen J. N., Chubb H., Slaney L., Kimata J., Bosire M., Ndinyaachola J. O., Ngugi E. N. 1989; Epidemiologic evidence for the development of serovar specific immunity after gonococcal infection. J Clin Invest 83:1472–1476
    [Google Scholar]
  29. Rice P. A., Vayo H. E., Tam M. R., Blake M. S. 1986 .; Immunoglobulin G antibodies directed against protein III block killing of serum resistant Neisseria gonorrhoeae by immune serum. . J Exp Med 164:1735–1748
    [Google Scholar]
  30. Ross S. C., Densen P. 1984; Complement deficiency states and infection: epidemiology, pathogenesis and consequences of Neisserial and other infections in an immune deficiency. Medicine 63:243–273
    [Google Scholar]
  31. Schagger H., von Jagow G. 1987; Tricine-sodium dodecyl sulphate polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368–379
    [Google Scholar]
  32. Virji M., Heckels J. E. 1984; The role of common and type-specific pilus antigenic domains in adhesion and virulence of gonococci for human epithelial cells. J Gen Microbiol 130:10891095.–10891095
    [Google Scholar]
  33. Virji M., Heckels J. E. 1985; Role of anti-pilus antibodies in host defense against gonococcal infection studied with monoclonal anti-pilus antibodies. Infect Immun 49:621–628
    [Google Scholar]
  34. Virji M., Heckels J. E. 1986; The effect of protein II and pili on the interaction of Neisseria gonorrhoeae with human polymorphonuclear leukocytes. J Gen Microbiol 132:503–512
    [Google Scholar]
  35. Virji M., Heckels J. E. 1988; Nonbactericidal antibodies against Neisseria gonorrhoeae : evaluation of their blocking effect on bactericidal antibodies directed against outer membrane antigens. J Gen Microbiol 134:2703–2711
    [Google Scholar]
  36. Virji M., Heckels J. E. 1989; Location of a blocking epitope on outer membrane protein III of Neisseria gonorrhoeae by synthetic peptide analysis. J Gen Microbiol 135:1895–1899
    [Google Scholar]
  37. Virji M., Zak K., Heckels J. E. 1986; Monoclonal antibodies to gonococcal outer membrane protein IB: use in investigation of thepotential protective effect of antibodies directed against conserved and type-specific epitopes. J Gen Microbiol 132:1621–1629
    [Google Scholar]
  38. Virji M., Fletcher J. N., Zak K., Heckels J. E. 1987; The potential protective effect of monoclonal antibodies to gonococcal outer membrane protein IA. J Gen Microbiol 133:2639–2646
    [Google Scholar]
  39. Ward M. E., Watt P. J., Glyn A. A. 1970; Gonococci in urethral exudates possess a virulence factor lost on subculture. Nature 227:382–384
    [Google Scholar]
  40. Wetzler L. M., Barry K., Blake M. S., Gotschlich E. C. 1992a; Gonococcal lipooligosaccharide sialylation prevents complement dependent killing by immune sera. Infect Immun 60:39–43
    [Google Scholar]
  41. Wetzler L. M., Blake M. S , Barry K, Gotschlich E. C. 1992b; Gonococcal porin vaccine evaluation: comparison of por proteosomes, liposomes, and blebs isolated from Rmp deletion mutants. J Infect Dis 166:551–555
    [Google Scholar]
  42. Zak K, Diaz. J. L, Jackson D, Heckels J. E. 1984; Antigenic variation during infection with Neisseria gonorrhoeae: detection of antibodies to surface proteins in sera of patients with gonorrhea. J Infect Dis 149:166–174
    [Google Scholar]
/content/journal/micro/10.1099/13500872-141-4-913
Loading
/content/journal/micro/10.1099/13500872-141-4-913
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error